Leading cancer treatment trials to improve patient outcomes
Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
This study is looking for cancer patients to join clinical trials that test new treatments, especially for rare cancers and those who might not usually get the best care, so they can help improve cancer treatment for everyone while possibly trying out the latest therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11248457 on NIH RePORTER |
What this research studies
This research focuses on participating in national clinical trials aimed at improving cancer treatment outcomes. The Case Comprehensive Cancer Center collaborates with major hospitals to conduct large-scale trials that address critical questions in cancer care, particularly for rare cancers and underrepresented populations. By enrolling approximately 240 new patients each year, the project aims to generate high-quality data that can influence treatment standards. Patients may have the opportunity to access cutting-edge therapies and contribute to significant advancements in cancer care.
Who could benefit from this research
Good fit: Ideal candidates include cancer patients, particularly those with rare cancers or from underrepresented populations, who are seeking innovative treatment options.
Not a fit: Patients with non-cancerous conditions or those not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for cancer patients.
How similar studies have performed: Previous research has shown success with similar large-scale clinical trials, indicating a strong potential for impactful findings.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Gerds, Aaron Thomas — Case Western Reserve University
- Study coordinator: Gerds, Aaron Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.